|
2006 testimonials
“In general the right people representing the antibody industry. We will come back”
Anon
“A great event with a high degree of case studies opening up for interesting discussions during the breaks”
Monica Ericsson, Senior Director, Biovitrum
“Excellent meeting relaxed informal atmosphere that encouraged good networking opportunities”
Prof Andy Porter, Chief Scientific Officer, Haptogen Ltd
“Good over views, right size , right people”
R.H Meloen, Chief Scientific Officer, Pepiscan BV
“Excellent networking opportunities, very good presentations”
Weidmann, Director, Morphosys
“Overall a very good specalised event”
Anon
“There were good chances to make business relationships”
Tae-Hein Lee, Senior Scientist, Daewoong
“High quality talks, not too big, good for networking
Michael Geromexia, Director R&D, Agenix Ltd
“Excellent two day forum with up to date info”
Cath Hutchings, Associate Director, Genzyme
“Excellently organized meeting. Speed networking and panel discussions were great additions to the normal conference set up”
Dr Dan Snell, Senior Scientist, Genzyme
“Good technical content on state of the art antibody selections and conjugation. Speed networking worked well – could have had a second session!”
Alastair Dent, Managing Director, Fleet Bioprocessing Ltd
“The networking opportunities were excellent”
Bob Lutz, Senior Director of Preclinical Development, Immunogen Inc
“Very high level of speakers, main state of the art topics present, networking sessions are a very good idea”
Jose Luis Abad, Senior Scientist, Biothirapix Molecular Medicines S.L.U
“This congress brought me back up to speed on antibody products and their characteristics”
Martin Comberbach, Managing Director, Comerbach Consulting Ltd
|
